DexCom, Inc. (DXCM)
66.34
+2.10
(+3.27%)
USD |
NASDAQ |
Mar 16, 16:00
66.66
+0.32
(+0.48%)
After-Hours: 20:00
DexCom Market Cap : 25.53B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 191.06B |
| Insulet Corp. | 15.82B |
| Krystal Biotech, Inc. | 7.313B |
| Boston Scientific Corp. | 103.56B |
| Tandem Diabetes Care, Inc. | 1.497B |
Market Cap Related Metrics
| PE Ratio | 31.70 |
| PS Ratio | 5.770 |
| PEG Ratio | 0.6756 |
| Price to Book Value | 9.298 |
| Price to Free Cash Flow | 24.97 |
| Price | 66.34 |
| Earnings Yield | 3.16% |
| PEGY Ratio | 0.6756 |
| Operating PE Ratio | 29.50 |
| Normalized PE Ratio | 31.70 |